Supreme Court PIL Challenges National HPV Vaccine Drive
The Supreme Court of India received a new public interest litigation challenging the government-backed HPV vaccination drive. Specifically, the petition questions the school-based administration of the human papillomavirus vaccine among adolescent girls. The Universal Health Organisation filed the plea to demand strict legal compliance before further rollout. Consequently, this legal challenge highlights crucial questions regarding bodily autonomy, transparent risk disclosure, and healthcare accountability.
Key Constitutional Concerns in the HPV Vaccination Drive
The petition contends that the programme violates Articles 14 and 21 of the Indian Constitution. In particular, the petitioners argue that administering vaccines in schools without robust parental consent compromises fundamental rights. Furthermore, the plea points to an absence of comprehensive risk disclosure for minor recipients and their guardians. Public health campaigns must preserve individual rights while pursuing vital disease prevention goals. Therefore, petitioners assert that public trust weakens when authorities bypass explicit informed consent protocols.
Historical Precedents and Safety Oversight
The petition cites the Parliamentary Standing Committee's 72nd Report from 2013 as an essential historical reference. Notably, that parliamentary report investigated ethical lapses during earlier HPV demonstration trials conducted in Andhra Pradesh and Gujarat. Because historical controversies linger, petitioners urge the court to prevent similar oversight failures in current public drives. Additionally, the plea demands an independent expert committee to review epidemiological data and vaccine safety profiles. This independent review would also evaluate available preventive alternatives such as routine cervical screening.
Calls for Surveillance Dashboards and Injury Compensation
Currently, the petitioner seeks immediate implementation of a real-time public reporting dashboard for adverse events. Such a mechanism would transparently monitor adverse events following immunisation across all Indian states. Moreover, the plea requests the notification of a formal vaccine injury compensation scheme for affected families. Many developed jurisdictions already maintain established compensation systems to protect vaccine recipients. Hence, instituting equivalent statutory safety nets would reassure parents and elevate public health integrity nationwide.
Clinical Implications for Healthcare Providers
Cervical cancer remains a leading cause of cancer mortality among Indian women. For this reason, medical practitioners strongly recognize the oncological value of human papillomavirus immunisation. However, doctors must ensure detailed communication with parents regarding potential benefits and known adverse effects. Transparent clinical discussions help bridge the gap between regulatory mandates and patient trust. As a result, healthcare teams can safeguard patient autonomy while supporting cervical cancer prevention efforts.
Frequently Asked Questions
Q1: Why is the HPV vaccination drive facing a challenge in the Supreme Court?
The public interest litigation challenges the HPV vaccination drive over the alleged absence of legally compliant informed consent, adequate risk disclosures, and statutory injury compensation mechanisms during school-based rollouts.
Q2: What did the 72nd Parliamentary Standing Committee Report highlight regarding HPV vaccines?
Presented in 2013, the 72nd Report examined ethical lapses, informed consent violations, and regulatory irregularities during earlier HPV vaccine demonstration studies conducted among young girls in India.
Q3: What specific remedies does the petition seek from the court?
The petition seeks the temporary suspension of school-based vaccination until authorities establish robust consent protocols, a real-time public adverse event dashboard, an independent expert safety review, and a national vaccine injury compensation scheme.
References
- PIL challenges Centre’s HPV vaccination drive, seeks Supreme Court interventionover consent, safety and accountability - ETHealthworld
- Measures taken to Strengthen HPV Vaccination Programme - Press Information Bureau (PIB), Government of India
- 72nd Report on Alleged Irregularities in the Conduct of Studies Using Human Papilloma Virus (HPV) Vaccine by PATH in India - Parliamentary Standing Committee on Health and Family Welfare, Rajya Sabha
